Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parsaclisib in primary warm autoimmune hemolytic anemia
NCT05073458Phase 3Terminated
- Sponsor
- Incyte
- Start
- Mar 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of parsaclisib in warm autoimmune hemolytic anemia (wAIHA), sponsored by Incyte. Started Mar 2022; status: terminated.
02
Drugs
parsaclisib
03
Conditions
warm autoimmune hemolytic anemia (wAIHA)
Beyond the preview
Go deeper on NCT05073458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05073458.